NAMOur WorkProgramsLeadership ConsortiumValue Incentives and Systems Approaches

Value Incentives & Systems Action Collaborative

Financial incentives that drive accountability for population health

About the Value Incentives & Systems Action Collaborative

As one of four action collaboratives under the National Academy of Medicine’s Leadership Consortium, the Value Incentives & Systems Action Collaborative (VISAC) seeks to identify financial incentives that drive individual and community health and well-being.

Health care in the United States is, in many circumstances, the best in the world. Yet we pay more for health care relative to other nations to get results that, on a population basis, are just mediocre. Moreover, health care is unaffordable for many in need. The prevailing approach to health care payment—which focuses predominantly on fees for individual services rendered—lies at the center of the issue. While promising initiatives are developing to redirect financial incentives away from volume, there is a need to better align financial incentives with individual and community health goals. While misplaced dollars are the issue, intentionally directing those dollars to value for population health goals is the solution.

To address this persistent gap between spending and value, the VISAC works with government leaders, industry executives, clinicians, and other critical stakeholders —to identify payment methods that are aligned with shared expectations for health system performance. The VISAC aims to move the U.S. toward a health system that is affordable, efficient, and accessible to everyone.

Co-Chairs

Dana Gelb Safran, ScD
President and CEO
National Quality Forum

Dana Gelb Safran is President & CEO of the National Quality Forum (NQF), and Chief Scientific Officer of the Joint Commission (TJC). In addition to overseeing NQF’s longstanding function as steward for our nation’s portfolio of healthcare quality measures, Dr. Safran is leading the expansion of NQF’s portfolio of products and services to advance healthcare quality, outcomes, equity and affordability, including new products and services being offered in partnership with the Joint Commission. Dr. Safran is an internationally recognized health care executive with a unique blend of accomplishment in business and academia. A central feature of her work has been combining the science of quality measurement with the art of its use to drive significant change in the quality, outcomes, and affordability of care. Dr. Safran’s prior roles include serving for more than a decade as a senior executive at Blue Cross Blue Shield of Massachusetts (BCBSMA), where she was a lead architect of the BCBSMA Alternative Quality Contract (AQC), which is widely credited with having catalyzed the value-based payment movement among public and private payers nationally. She was also a founding member of the executive team at Haven, a joint venture of Amazon, Berkshire Hathaway, and JPMorgan Chase to achieve better health outcomes, care experiences, and costs of care through innovation in care delivery, benefit design and purchasing. Dr. Safran is on the faculty of Tufts University School of Medicine and has held a broad range of advisory roles in the public sector and internationally supporting efforts to improve health and health care through effective uses of performance measurement. From 2017-2023, she served as a Commissioner of the Medicare Payment Advisory Commission (MedPAC). She holds a BA in Biology and Government from Wesleyan University and completed her post-graduate studies at the Harvard School of Public Health to earn an ScM and ScD in Health Policy and Management.

 

Jaewon Ryu, MD, JD
CEO
Risant Health

Jaewon Ryu, MD, JD, is the CEO of Risant Health, after having served as the President and CEO of Geisinger, its inaugural member organization. Risant Health is a nonprofit organization created by Kaiser Permanente to expand and accelerate the adoption and success of value-based care in diverse, multi-payer, multi-provider, health system environments across the country. By doing so, it seeks to improve the health of the communities it serves, achieve better health outcomes, and improve health care affordability.

Dr. Ryu came to Geisinger in 2016 from Humana, where he was responsible for the company’s care delivery assets and capabilities, and previously, he held various leadership roles at the University of Illinois Hospital & Health Sciences System, Kaiser Permanente, and in government at the Centers for Medicare and Medicaid Services and as a White House Fellow placed at the Department of Veterans Affairs. He started his career as a practicing corporate healthcare attorney.

Dr. Ryu recently completed a full, two-term stint (2018-2024) on the Medicare Payment Advisory Commission (MedPAC), a body legislatively tasked with advising Congress on policies governing health plans and providers serving Medicare beneficiaries. Currently, he serves on the boards of various organizations including the National Committee for Quality Assurance (NCQA) and the Commonwealth Fund.

Dr. Ryu earned his B.A. from Yale University and his M.D. and J.D. from the University of Chicago. He completed his residency training in emergency medicine at Harbor-UCLA Medical Center.